Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.
O'Neill
K L
KL
Zhang
F
F
Li
H
H
Fuja
D G
DG
Murray
B K
BK
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D008297:Male; D009363:Neoplasm Proteins / Q000097:blood*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D011379:Prognosis; D013937:Thymidine Kinase / Q000097:blood*; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D013937:Thymidine Kinase; C092717:thymidine kinase 1